mRNA technology: navigating preclinical research for rare diseases
Philip Cruz, Country Medical Director at Moderna UK talks about the potential of mRNA technology for rare diseases in a blog for Rare Disease Day 2024.
Read the full articleYou might also wanna read
MEP calls for Ireland to increase testing done on newborn babies for rare conditions
TheJournal.ie·21h ago
The UK should seek to be a European leader for rare disease medicine, says new report
ABPI·4d ago
ABPI response to publication of England's Rare Diseases Action Plan 2026
ABPI·4d ago
ABPI response to England's 2023 Rare Disease Action Plan
ABPI·4d ago
ABPI response to Northern Ireland's Rare Diseases Action Plan
ABPI·4d ago
ABPI response to England Rare Diseases Action Plan
ABPI·4d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.